Short interest in Contineum Therapeutics Inc (NASDAQ:CTNM) increased during the last reporting period, rising from 553.60K to 738.37K. This put -% of the company's publicly available shares short.

Short interest for Contineum Therapeutics gives investors a sense of the degree to which investors are betting on the decline of Contineum Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 263.36K shares traded per day, it would take 2.8 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.